Statement On The FDA Approval Of The First Extended-Release, Injectable Drug For Adults Living With HIV
Skip to Main Content
Click to read notice

COVID-19 Updates: For more information about COVID-19 vaccinations and testing, please click here.

Statement On The FDA Approval Of The First Extended-Release, Injectable Drug For Adults Living With HIV

Jan 22, 2021

“Today is an extremely exciting day. For the first time, people living with HIV will have the option to use a long-acting injectable medication that can be administered once a month – instead of taking a daily pill. This is an important step forward in the treatment for HIV. It builds on more than 35 years of medical breakthroughs that will eventually help us to End the HIV Epidemic. Trillium Health hopes to have the medication available to its patients within the next several weeks. We encourage our patients to talk to their provider to see if it’s right for them.”

###

About Trillium Health

As a Federally Qualified Health Center, Trillium Health's mission is to promote health equity by providing affordable and extraordinary primary and specialty health care to all, including LGBTQ+ communities, in Rochester, New York. Its comprehensive model of care ensures care for people from all backgrounds, regardless of income, sexual orientation, gender identity, race, or ethnicity. For more information, please visit www.trilliumhealth.org.